Headache Diary for Migraine Patients
ConditionMigraine
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorHackensack Meridian Health
About this trial
Use of a headache journal/calendar in patients who have migraine to ascertain if keeping a headache journal affects the quality of life and the headache burden.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adults diagnosed with migraine (episodic or chronic) according to ICHD-3 criteria, with at least 3 months of confirmed diagnosis. Both episodic migraine (≤14 headache days/month) and chronic migraine (≥15 headache days/month) are eligible and will be recorded as a demographic subgroup variable.
Disqualifiers
Individuals under the age of 18
Non-English speaking individuals
Trial design
Design model
Single group
Treatments tested in this trial
Headache diary
BehavioralCompletion of the virtual diary/calendar
Treatment groups
50 Participants
are divided into 1 treatment groupGroup A: Headache diaryExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Migraine Specific Quality of Life
Migraine Specific Quality of Life using the MSQv2.1, a 14-item validated assessment used to measure how migraines affect a patient's daily functioning and well-being. Each of the 14 questions is scored using a 6-point scale ranging from 1 ("Always") to 6 ("Never"). The raw scores for each of the three domains are transformed into a standardized 0 to 100 scale, where higher scores indicate a better quality of life (less impact/disability from migraine).
Time frame
Baseline, 4 weeks, 8 weeks, 12 weeks, and 24 weeksSecondary outcomes
1
Migraine Disability Assessment (MIDAS) score
To determine whether headache burden has decreased, as measured by the Migraine Disability Assessment (MIDAS). MIDAS is a standard questionnaire used by neurologists and primary care providers to measure how severely migraines impact your daily life and work capacity. Scores range from 0 (no disability) to 21+ (severe disability) based on the number of days from a migraine event.
Time frame
Baseline, 4 weeks, 8 weeks, 12 weeks, and 24 weeksLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: